CDKN2B-AS1 and gastric cancer: Consistent with previous studies (31,32), we found that ANRIL knockdown could significantly inhibit gastric cancer cell viability, migration, and invasion, and promoted apoptosis in MKN-45 and SGC-7901 cells in vitro, consolidating that ANRIL played an important role in gastric cancer progression.